1. Zhou, Jingying, Liu, Man, Sun, Hanyong, To, Ka Fai, Cheng, Alfred Sze-Lok. 2017. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. In Gut, 67, 931-944. doi:10.1136/gutjnl-2017-314032. https://pubmed.ncbi.nlm.nih.gov/28939663/
2. Ashraf, Shazia, Kudo, Hiroki, Rao, Jia, Kure, Shigeo, Hildebrandt, Friedhelm. 2018. Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. In Nature communications, 9, 1960. doi:10.1038/s41467-018-04193-w. https://pubmed.ncbi.nlm.nih.gov/29773874/
3. Satoda, Yuuki, Noguchi, Tatsuro, Fujii, Taiju, Katoh, Yohei, Nakayama, Kazuhisa. 2022. BROMI/TBC1D32 together with CCRK/CDK20 and FAM149B1/JBTS36 contributes to intraflagellar transport turnaround involving ICK/CILK1. In Molecular biology of the cell, 33, ar79. doi:10.1091/mbc.E22-03-0089. https://pubmed.ncbi.nlm.nih.gov/35609210/
4. Wu, Ya Meng, Sa, Yu, Guo, Yu, Li, Qi Feng, Zhang, Ning. . Identification of WHO II/III Gliomas by 16 Prognostic-related Gene Signatures using Machine Learning Methods. In Current medicinal chemistry, 29, 1622-1639. doi:10.2174/0929867328666210827103049. https://pubmed.ncbi.nlm.nih.gov/34455959/
5. Hussain Qureshi, Muhammad Fazal, Shah, Muzna, Lakhani, Mahira, Shamim, Mushtaq, Ghulam, Haider. 2021. Gene signatures of cyclin-dependent kinases: a comparative study in naïve early and advanced stages of lung metastasis breast cancer among pre- and post-menopausal women. In Genes & cancer, 12, 1-11. doi:10.18632/genesandcancer.209. https://pubmed.ncbi.nlm.nih.gov/33868579/
智鼠故事 
